Saturday, January 22, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina

NEWS

NEWS

PAHO greets inclusion of anti-Covid vaccine produced in Latin America

vacunas

PAHO greets inclusion of anti-Covid vaccine produced in Latin America

Washington, Dec 24 (Prensa Latina) The Pan American Health Organization (PAHO) today celebrated the inclusion in the list for emergency use of the recombinant anti-Covid-19 Vaxzevria vaccine (AZD1222), produced jointly by Argentina and Mexico.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

“This is an important milestone for Latin America and highlights the importance of technology transfer to increase the availability of quality drugs in the region,” said the agency’s director, Carissa F. Etienne.

The drug, from the Anglo-Swedish pharmaceutical company AstraZeneca, is being developed by the Argentine company mAbxience and the Mexican company Laboratorios Liomont and, according to PAHO, is already being used in some countries, but the approval will facilitate its acquisition and distribution.

The decision adopted by the World Health Organization (WHO), the PAHO communiqué stressed, comes as the pandemic enters its third consecutive year and the Americas are seeing a steady increase in cases of SARS-CoV-2, the coronavirus that causes Covid-19.

In the last week, the region reported more than 1.1 million new infections with the disease, a six percent increase over the previous week.

Seven days ago, WHO approved the ninth vaccine, called CovovaxTM, produced by the Serum Institute of the United States, under license from U.S. manufacturer Novavax.

ef/abo/mgt/znc

RELATED
ÚLTIMO MINUTO
name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.